肿瘤坏死因子阻滞剂浓度高的类风湿关节炎患者逐渐减药且无复发：来自STRASS研究的数据 - Suppr

Suppr

超能文献

Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from STRASS study.

作者信息

Marotte Hubert, Rinaudo-Gaujous Mélanie, Petiet Cécile, Fautrel Bruno, Paul Stéphane

机构信息

Rhumatologie, CHU Saint-Etienne, Saint-Etienne, France

SAINBIOSE, INSERM U1059, University of Lyon, Saint-Etienne, France.

出版信息

Ann Rheum Dis. 2020 Jul;79(7):e81. doi: 10.1136/annrheumdis-2019-215546. Epub 2019 May 2.

DOI:10.1136/annrheumdis-2019-215546

PMID:31048287

Abstract

摘要

相似文献

Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from STRASS study.

Ann Rheum Dis. 2020 Jul;79(7):e81. doi: 10.1136/annrheumdis-2019-215546. Epub 2019 May 2.

Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte .

Ann Rheum Dis. 2020 Jul;79(7):e82. doi: 10.1136/annrheumdis-2019-215609. Epub 2019 May 9.

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study).

Ann Rheum Dis. 2016 Jan;75(1):59-67. doi: 10.1136/annrheumdis-2014-206696. Epub 2015 Jun 23.

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.

Cochrane Database Syst Rev. 2014 Sep 29(9):CD010455. doi: 10.1002/14651858.CD010455.pub2.

Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial.

Value Health. 2017 Apr;20(4):577-585. doi: 10.1016/j.jval.2017.01.005. Epub 2017 Mar 10.

Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.

Clin Exp Rheumatol. 2023 Sep;41(9):1831-1837. doi: 10.55563/clinexprheumatol/eonoj3. Epub 2023 Jul 24.

Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.

J Manag Care Pharm. 2013 Oct;19(8):621-30. doi: 10.18553/jmcp.2013.19.8.621.

Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.

Cochrane Database Syst Rev. 2019 May 24;5(5):CD010455. doi: 10.1002/14651858.CD010455.pub3.

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.

PLoS One. 2020 Mar 23;15(3):e0229819. doi: 10.1371/journal.pone.0229819. eCollection 2020.

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial.

Ann Rheum Dis. 2020 Dec;79(12):1550-1556. doi: 10.1136/annrheumdis-2020-217528. Epub 2020 Sep 9.

引用本文的文献

Tapering of biological treatment in autoinflammatory diseases: a scoping review.

Pediatr Rheumatol Online J. 2022 Aug 13;20(1):67. doi: 10.1186/s12969-022-00725-3.

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501).

BMC Immunol. 2021 Dec 25;22(1):81. doi: 10.1186/s12865-021-00473-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验